eConvergence Inc. provides innovative products that enhance quality of life by helping people worldwide see better. Its Surgical and Vision Care businesses offer a wide spectrum of eye care products. For your new drug to reach its intended market after launch, it takes ongoing clinical data management and multi-pronged marketing. Safety data from larger populations expand trust and show regulatory compliance, while tactical marketing to key players builds recognition as it accelerates product acceptance, formulary adoption and recommendation by health professionals.
eConvergence Inc offers a Platform offering to manage drug safety and pharmacovigilance. We have acquired expertise in 11 therapeutic areas of drug safety through our work experience of more than seven years with Pharmaceutical majors across the globe. We have over 100 highly qualified and trained Healthcare Professionals who are experienced in Argus and ARISg safety database.
In line with our strong quality processes, we have process frameworks in place for increased RIGHT FIRST TIME capabilities. We are the largest Argus trained user base in India for one of the Pharmaceutical majors.
As a company that was started by a scientist, eConvergence Inc fosters a culture where scientific temperament is rooted in our people and our approach to research. Our research efforts are geared toward accelerating access to affordable and innovative medicines. We focus our work on being first to market with products that are difficult to customer health. Why? These tough-to-make products are likely to be very harm, and our unique capabilities allow us to improve accessibility to them. Similarly, our patient-centric approach means we tend to focus on developing differentiated products that best address unmet patient needs.
Wide-ranging suite of capabilities and services—from synthetic organic chemistry to formulations development, from intellectual property management to regulatory science from polymorphism to bio-pharmaceutics. For our industry customers, we’re able to offer services and solutions for starting material, intermediates, active ingredients and finished-dosage forms.
At its launch, information on a medicine reflects evidence from preclinical studies and clinical trials conducted in, at most, a few thousand patients. A fuller profile of adverse effects emerges only after a medicine has been in clinical use, clarify the frequency of some effects, reveal rare new adverse reactions, and better understand what makes individuals susceptible to some adverse effects.
"To empower patients with the knowledge to better manage their own healthcare and to improve consumer safety by assisting in the reduction of medication errors."
Efficacy is the largest, most widely visited, independent medicine information website available on the Internet. Our aim is to be the Internet’s most trusted resource for drug and related health information. We will achieve this aim by presenting independent, objective, comprehensive and up-to-date information in a clear and concise format for both consumers and healthcare professionals.
Read More...